Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective

• L. Minig ^[1] ; J. de Santiago ^[2] ; S. Domingo ^[5] ; A. Gil-Moreno ^[6] ; S. Martínez ^[3] ; A. Rodríguez-Garzotto ^[7] ; L. Chiva ^[4]
  1. [1] Universidad CEU Cardenal Herrera

     Universidad CEU Cardenal Herrera

     Valencia, España

     
  2. [2] University of Texas MD Anderson Cancer Center

     University of Texas MD Anderson Cancer Center

     Estados Unidos

     
  3. [3] Hospital Universitari Germans Trias i Pujol

     Hospital Universitari Germans Trias i Pujol

     Barcelona, España

     
  4. [4] Clínica Universitaria de Navarra

     Clínica Universitaria de Navarra

     Pamplona, España

     
  5. [5] Hospital Politécnico La Fe
  6. [6] Hospital Vall d´Hebron
  7. [7] Departamento Médico y Estrategia Madrid

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 5 (May), 2019, págs. 656-664
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Background Optimal upfront treatment of patients with advanced ovarian cancer is complex and requires the adequate function of a multidisciplinary team. Specific standard of quality of care needs to be taken into consideration.

    Methods A literature search in PubMed was performed using the following criteria: (“ovarian neoplasms”[MeSH Terms] OR (“ovarian”[All Fields] AND “neoplasms”[All Fields]) OR “ovarian neoplasms”[All Fields] OR (“ovarian”[All Fields] AND “cancer”[All Fields]) OR “ovarian cancer”[All Fields])“[Date - Publication]: “2018/01/14”[Date - Publication]).

    Results This article describes how to optimize the surgical management of advanced ovarian cancer, to achieve the best results in terms of survival and quality of life. For this purpose, this document will cover aspects related to pre-, intra- and postoperative care of newly diagnosed advanced ovarian cancer patients.

    Conclusion Optimizing upfront treatment of patients with advanced ovarian cancer is complex and requires a structured quality management program including the wise judgment of a multidisciplinary team. Surgeries performed by gynecologic oncologists with formal training in cytoreductive techniques at referral centers are crucial factors to obtain better clinical and oncological outcomes. However, other factors such as the patient’s clinical status, the hospital infrastructure and equipment, as well as the tumor biology of each individual patient should also be taken into account before deciding on an initial therapeutic strategy for advanced-stage ovarian cancer to offer patients the best quality of care.